2021 ICD-10-CM Diagnosis Code C93.30

Juvenile myelomonocytic leukemia, not having achieved remission

    2016 2017 2018 2019 2020 2021 Billable/Specific Code Pediatric Dx (0-17 years)
  • C93.30 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • Short description: Juvenile myelomonocytic leukemia, not achieve remission
  • The 2021 edition of ICD-10-CM C93.30 became effective on October 1, 2020.
  • This is the American ICD-10-CM version of C93.30 - other international versions of ICD-10 C93.30 may differ.
ICD-10-CM Coding Rules
  • C93.30 is applicable to pediatric patients aged 0 - 17 years inclusive.
Applicable To
  • Juvenile myelomonocytic leukemia with failed remission
  • Juvenile myelomonocytic leukemia NOS
The following code(s) above C93.30 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to C93.30:
  • C00-D49
    2021 ICD-10-CM Range C00-D49

    Neoplasms

    Note
    • Functional activity
    • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
    • Morphology [Histology]
    • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
    • Primary malignant neoplasms overlapping site boundaries
    • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
    • Malignant neoplasm of ectopic tissue
    • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
    Neoplasms
  • C81-C96
    2021 ICD-10-CM Range C81-C96

    Malignant neoplasms of lymphoid, hematopoietic and related tissue

    Type 2 Excludes
    • Kaposi's sarcoma of lymph nodes (C46.3)
    • secondary and unspecified neoplasm of lymph nodes (C77.-)
    • secondary neoplasm of bone marrow (C79.52)
    • secondary neoplasm of spleen (C78.89)
    Malignant neoplasms of lymphoid, hematopoietic and related tissue
  • C93
    ICD-10-CM Diagnosis Code C93

    Monocytic leukemia

      2016 2017 2018 2019 2020 2021 Non-Billable/Non-Specific Code
    Includes
    • monocytoid leukemia
    Type 1 Excludes
    • personal history of leukemia (Z85.6)
    Monocytic leukemia
Approximate Synonyms
  • Juvenile myelomonocytic leukemia
  • Myelomonocytic leukemia, juvenile
Clinical Information
  • A leukemia affecting young children characterized by splenomegaly, enlarged lymph nodes, rashes, and hemorrhages. Traditionally classed as a myeloproliferative disease, it is now considered a mixed myeloproliferative-mylelodysplastic disorder.
  • A myelodysplastic/myeloproliferative neoplasm of childhood that is characterized by proliferation principally of the granulocytic and monocytic lineages. Myelomonocytic proliferation is seen in the bone marrow and the blood. The leukemic cells may infiltrate any tissue, however liver, spleen, lymph nodes, skin, and respiratory tract are the most common sites of involvement. The prognosis is usually poor. (who, 2001)
  • A rare form of childhood leukemia in which cancer cells often spread into tissues such as the skin, lung, and intestines.
ICD-10-CM C93.30 is grouped within Diagnostic Related Group(s) (MS-DRG v38.0):
  • 820 Lymphoma and leukemia with major o.r. Procedures with mcc
  • 821 Lymphoma and leukemia with major o.r. Procedures with cc
  • 822 Lymphoma and leukemia with major o.r. Procedures without cc/mcc
  • 823 Lymphoma and non-acute leukemia with other procedures with mcc
  • 824 Lymphoma and non-acute leukemia with other procedures with cc
  • 825 Lymphoma and non-acute leukemia with other procedures without cc/mcc
  • 840 Lymphoma and non-acute leukemia with mcc
  • 841 Lymphoma and non-acute leukemia with cc
  • 842 Lymphoma and non-acute leukemia without cc/mcc

Convert C93.30 to ICD-9-CM

Code History
  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
ICD-10-CM Codes Adjacent To C93.30
C93 Monocytic leukemia
C93.0 Acute monoblastic/monocytic leukemia
C93.00 …… not having achieved remission
C93.01 …… in remission
C93.02 …… in relapse
C93.1 Chronic myelomonocytic leukemia
C93.10 …… not having achieved remission
C93.11 …… in remission
C93.12 …… in relapse
C93.3 Juvenile myelomonocytic leukemia
C93.30 …… not having achieved remission
C93.31 …… in remission
C93.32 …… in relapse
C93.Z Other monocytic leukemia
C93.Z0 …… not having achieved remission
C93.Z1 …… in remission
C93.Z2 …… in relapse
C93.9 Monocytic leukemia, unspecified
C93.90 …… not having achieved remission
C93.91 …… in remission
C93.92 …… in relapse

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.